Aliski William

Director at Ultragenyx Pharmaceutical Inc. · on record since Jan 30, 2014
Director at APPLIED GENETIC TECHNOLOGIES CORP · on record since Sep 24, 2018
Director at X4 Pharmaceuticals, Inc · on record since Sep 20, 2019

Insider trading activity of Aliski William

Transactions on record: 72; since Feb 3, 2014

Open-market buys: 4; $124.5K

Open-market sells: 16; $6.6M

Companies traded: 3; last filing Jun 11, 2024

Figures computed from official regulatory filings — .

Companies where Aliski William has traded

X4 Pharmaceuticals, Inc6 tx · $57K · Jun 11, 2024
APPLIED GENETIC TECHNOLOGIES CORP14 tx · $19.5K · Dec 1, 2022
Ultragenyx Pharmaceutical Inc.52 tx · $8.5M · Jun 28, 2021

Track record of Aliski William

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Aliski William

Co-insiders of Aliski William

AGARWAL SUNILUltragenyx Pharmaceutical Inc.
Alta Partners Management VIII, LLCAPPLIED GENETIC TECHNOLOGIES CORP
Alta Partners VIII, L.P.APPLIED GENETIC TECHNOLOGIES CORP
Arbet-Engels ChristopheX4 Pharmaceuticals, Inc
Ashe Andrew D.APPLIED GENETIC TECHNOLOGIES CORP
Baldry MarkX4 Pharmaceuticals, Inc
Bedrosian Camille LUltragenyx Pharmaceutical Inc.
BLECH ISAACX4 Pharmaceuticals, Inc
Bridger GaryX4 Pharmaceuticals, Inc
BULLOCK LAWRENCE EAPPLIED GENETIC TECHNOLOGIES CORP
Cadavid DiegoX4 Pharmaceuticals, Inc
Carroll JillAPPLIED GENETIC TECHNOLOGIES CORP
CASH HARVEY BAPPLIED GENETIC TECHNOLOGIES CORP
CHAMPSI FARAHAPPLIED GENETIC TECHNOLOGIES CORP
Chulay Jeffrey D.APPLIED GENETIC TECHNOLOGIES CORP
COULTER JAMES GUltragenyx Pharmaceutical Inc.
Craig Adam RX4 Pharmaceuticals, Inc
Crombez EricUltragenyx Pharmaceutical Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
X4 Pharmaceuticals, IncListing on record	Jun 11, 2024	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-14,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	Other	-8,500	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-12,000	—	n/a (No price was disclosed in the filing)		SEC
X4 Pharmaceuticals, IncListing on record	Jun 27, 2022	Award	6,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 2, 2021	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 28, 2021	AwardD (derivative)	4,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 28, 2021	Award	2,145	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 2, 2021	AwardD (derivative)	6,000	9.50 USD	$57K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	ExerciseD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Sell	-7,500	149.01 USD	$1.1M	Unusual size	SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Exercise	7,500	97.85 USD	$733.9K	Unusual size	SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 3, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 3, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 18, 2020	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	Sell	-5,000	86.57 USD	$432.8K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	Exercise	5,000	58.74 USD	$293.7K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 30, 2020	Award	2,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 30, 2020	AwardD (derivative)	4,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
X4 Pharmaceuticals, IncListing on record	Jun 11, 2024	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 14, 2023	Award	45,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-14,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-10,000	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	Other	-8,500	—	n/a (No price was disclosed in the filing)		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 1, 2022	OtherD (derivative)	-12,000	—	n/a (No price was disclosed in the filing)		SEC
X4 Pharmaceuticals, IncListing on record	Jun 27, 2022	Award	6,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 2, 2021	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 28, 2021	AwardD (derivative)	4,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 28, 2021	Award	2,145	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
X4 Pharmaceuticals, IncListing on record	Jun 2, 2021	AwardD (derivative)	6,000	9.50 USD	$57K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	ExerciseD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Sell	-7,500	149.01 USD	$1.1M	Unusual size	SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 23, 2021	Exercise	7,500	97.85 USD	$733.9K	Unusual size	SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 3, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Feb 3, 2021	Gift	-1,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
APPLIED GENETIC TECHNOLOGIES CORPListing unverified	Dec 18, 2020	AwardD (derivative)	12,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	Sell	-5,000	86.57 USD	$432.8K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	Exercise	5,000	58.74 USD	$293.7K		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Aug 25, 2020	ExerciseD (derivative)	-5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 30, 2020	Award	2,550	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ultragenyx Pharmaceutical Inc.Listing on record	Jun 30, 2020	AwardD (derivative)	4,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC